Scinopharm Taiwan (TPE:1789) E10: NT$0.52 (As of Dec. 2025)


TPE:1789 Scinopharm Taiwan Ltd TPE:1789
76 GF Score
Price NT$20.00
GF Value NT$27.02
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Scinopharm Taiwan E10?

Scinopharm Taiwan TPE:1789 -2.68% 76 E10 is NT$0.52 as of Dec. 2025. GuruFocus rates TPE:1789 with a GF Score™ of 76/100 and a GF Value™ of NT$27.02 (Modestly Undervalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Scinopharm Taiwan's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$0.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$0.52 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Scinopharm Taiwan's average E10 Growth Rate was -11.90% per year. During the past 3 years, the average E10 Growth Rate was -12.60% per year. During the past 5 years, the average E10 Growth Rate was -11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Scinopharm Taiwan was -12.50% per year. The lowest was -12.60% per year. And the median was -12.50% per year.

As of today (2026-06-28), Scinopharm Taiwan's current stock price is NT$20.00. Scinopharm Taiwan's E10 for the quarter that ended in Dec. 2025 was NT$0.52. Scinopharm Taiwan's Shiller PE Ratio of today is 38.46.

During the past 13 years, the highest Shiller PE Ratio of Scinopharm Taiwan was 50.48. The lowest was 25.16. And the median was 32.15.


Scinopharm Taiwan  (TPE:1789) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Scinopharm Taiwan's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=20.00/0.52
=38.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Scinopharm Taiwan was 50.48. The lowest was 25.16. And the median was 32.15.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Scinopharm Taiwan E10 Related Terms


Scinopharm Taiwan E10 Historical Data

* Premium members only.

The historical data trend for Scinopharm Taiwan's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scinopharm Taiwan E10 Chart

Scinopharm Taiwan Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 0.78 0.63 0.59 0.52

Scinopharm Taiwan Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.59 0.57 0.55 0.52

TPE:1789 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Scinopharm Taiwan's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scinopharm Taiwan Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Scinopharm Taiwan's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Scinopharm Taiwan's Shiller PE Ratio falls into.


TPE:1789
76GF Score
Scinopharm Taiwan Ltd TPE:1789
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scinopharm Taiwan E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scinopharm Taiwan's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0.05/324.0540*324.0540
=0.050

Current CPI (Dec. 2025) = 324.0540.

Scinopharm Taiwan Quarterly Data

per share eps CPI Adj_EPS
201603 0.221 238.132 0.301
201606 0.221 241.018 0.297
201609 0.210 241.428 0.282
201612 0.180 241.432 0.242
201703 0.210 243.801 0.279
201706 0.110 244.955 0.146
201709 0.140 246.819 0.184
201712 0.070 246.524 0.092
201803 0.170 249.554 0.221
201806 0.170 251.989 0.219
201809 0.100 252.439 0.128
201812 0.120 251.233 0.155
201903 0.100 254.202 0.127
201906 0.070 256.143 0.089
201909 0.040 256.759 0.050
201912 0.060 256.974 0.076
202003 0.040 258.115 0.050
202006 0.200 257.797 0.251
202009 0.100 260.280 0.125
202012 0.010 260.474 0.012
202103 0.110 264.877 0.135
202106 0.110 271.696 0.131
202109 0.010 274.310 0.012
202112 0.070 278.802 0.081
202203 0.100 287.504 0.113
202206 0.140 296.311 0.153
202209 0.080 296.808 0.087
202212 0.130 296.797 0.142
202303 0.050 301.836 0.054
202306 0.070 305.109 0.074
202309 0.040 307.789 0.042
202312 0.200 306.746 0.211
202403 0.180 312.332 0.187
202406 0.090 314.175 0.093
202409 0.030 315.301 0.031
202412 0.120 315.605 0.123
202503 0.060 319.799 0.061
202506 0.040 322.561 0.040
202509 0.020 324.800 0.020
202512 0.050 324.054 0.050

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$0.52 mean?
Scinopharm Taiwan (TPE:1789) has a E10 of NT$0.52 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Scinopharm Taiwan and its competitors.
Is Scinopharm Taiwan's E10 too high?
Scinopharm Taiwan's current E10 is NT$0.52. Overall, Scinopharm Taiwan has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Scinopharm Taiwan's E10 compare to ZTS and UTHR?
Scinopharm Taiwan's E10 of NT$0.52 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Scinopharm Taiwan and its competitors. Scinopharm Taiwan's current E10 is NT$0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scinopharm Taiwan stock overvalued right now?
Based on GuruFocus' analysis, Scinopharm Taiwan (TPE:1789) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$27.02, compared to a current price of NT$20.00 — trading 26% below its estimated fair value. The current E10 is NT$0.52. Scinopharm Taiwan's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Scinopharm Taiwan (TPE:1789), the current E10 is NT$0.52 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scinopharm Taiwan (TPE:1789) Overvalued in 2026?

Based on GuruFocus' analysis, Scinopharm Taiwan stock appears to be undervalued. The current stock price of NT$20.00 is trading 26% below its estimated GF Value™ of NT$27.02. GuruFocus considers Scinopharm Taiwan to be Modestly Undervalued.

Key valuation signals for TPE:1789:

  • E10: NT$0.52
  • GF Value™: NT$27.02 vs. price of NT$20.00 (26% below fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the TPE:1789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scinopharm Taiwan Business Description

Address Nan-Ke 8th Road, No. 1, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144
Scinopharm Taiwan Ltd is mainly engaged in the manufacture of western medicines and other chemical materials, biological technology services, intellectual property rights, international trade, and the research, development, production, manufacture, and sales of Active Pharmaceutical Ingredients (API), albumin medicines, oligonucleotide medicines, peptide medicines, injections, and new small molecule drugs. The Company also provides related consulting and technical services and international trade for the above products. In addition, the Company sells chemical material reprocessed from material recycled from the Company's manufacturing process.
76GF Score

Get the complete analysis for TPE:1789

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.00
Price
NT$27.02
GF Value